LifeMD, Inc. (NASDAQ:LFMDP) Short Interest Update

LifeMD, Inc. (NASDAQ:LFMDPGet Free Report) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totalling 300 shares, a growth of 200.0% from the September 30th total of 100 shares. Based on an average daily trading volume, of 2,100 shares, the short-interest ratio is presently 0.1 days.

LifeMD Stock Performance

Shares of LifeMD stock opened at $22.23 on Friday. The business has a fifty day simple moving average of $22.17 and a 200-day simple moving average of $22.19. LifeMD has a fifty-two week low of $17.15 and a fifty-two week high of $25.00.

LifeMD Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Friday, October 4th were given a dividend of $0.5547 per share. This represents a $2.22 dividend on an annualized basis and a dividend yield of 9.98%. The ex-dividend date of this dividend was Friday, October 4th.

About LifeMD

(Get Free Report)

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.

See Also

Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.